{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:14:35Z","timestamp":1773371675817,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:00:00Z","timestamp":1794614400000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K10089"],"award-info":[{"award-number":["25K10089"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jiac.2025.102859","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T02:53:14Z","timestamp":1762829594000},"page":"102859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of continuous hemodiafiltration on serum acyclovir concentrations in a patient with encephalopathy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-4443","authenticated-orcid":false,"given":"Takahiro","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Itohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5254-3507","authenticated-orcid":false,"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Kitahiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-253X","authenticated-orcid":false,"given":"Tomohiro","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9517-5628","authenticated-orcid":false,"given":"Ikuko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102859_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26041132","article-title":"Advances and perspectives in the management of varicella-zoster virus infections","volume":"26","author":"Andrei","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jiac.2025.102859_bib2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jiac.2023.07.001","article-title":"A decreasing plasma concentration of a toxicologically active metabolite 9-carboxymethoxymethylguanine after dialysis - a potential new clinical biomarker for improving encephalopathy in patients treated with acyclovir","volume":"29","author":"Unita","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102859_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026147","article-title":"Acute kidney injury and acyclovir-associated encephalopathy after administration of valacyclovir in an elderly person with normal renal function: a case report and literature review","volume":"100","author":"Kenzaka","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jiac.2025.102859_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s13730-022-00748-5","article-title":"Valacyclovir-associated acute kidney injury and encephalopathy in an elderly woman with normal kidney function: a case report","volume":"12","author":"Kato","year":"2023","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.jiac.2025.102859_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/IJGM.S291320","article-title":"Encephalopathy induced by preventive administration of acyclovir in a man with symptomatic multiple myeloma and renal dysfunction","volume":"14","author":"Sugimoto","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jiac.2025.102859_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/clpt.1981.218","article-title":"Disposition of intravenous radioactive acyclovir","volume":"30","author":"de Miranda","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jiac.2025.102859_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0090-9556(25)08306-0","article-title":"Metabolic fate and pharmacokinetics of the acyclovir prodrug valaciclovir in cynomolgus monkeys","volume":"22","author":"de Miranda","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jiac.2025.102859_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0002-9343(82)90088-2","article-title":"Overview of acyclovir pharmacokinetic disposition in adults and children","volume":"73","author":"Blum","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2025.102859_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1570-0232(02)00538-X","article-title":"Liquid chromatographic method for the determination of ganciclovir and\/or acyclovir in human plasma using pulsed amperometric detection","volume":"780","author":"Kishino","year":"2002","journal-title":"J Chromatogr, B: Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.jiac.2025.102859_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/FTD.0000000000001257","article-title":"Pharmacokinetic and pharmacodynamic assessment of valganciclovir in infants with congenital cytomegalovirus infection","volume":"47","author":"Itohara","year":"2025","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jiac.2025.102859_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113852","article-title":"Therapeutic monitoring of serum concentrations of acyclovir and its metabolite 9-(carboxymethoxymethyl) guanine in routine clinical practice","volume":"156","author":"Kacirova","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jiac.2025.102859_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0002-9343(82)90090-0","article-title":"Effect of renal failure on the pharmacokinetics of acyclovir","volume":"73","author":"Laskin","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2025.102859_bib14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3389\/fphar.2019.00874","article-title":"Risk evaluation for acute kidney injury induced by the concomitant use of valacyclovir, analgesics, and renin-angiotensin system inhibitors: the detection of signals of drug-drug interactions","volume":"10","author":"Inaba","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiac.2025.102859_bib15","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1007\/s12325-017-0643-3","article-title":"The influence of hepatic and renal impairment on the pharmacokinetics of a treatment for herpes zoster, amenamevir (asp2151): phase 1, open-label, single-dose, parallel-group studies","volume":"34","author":"Kusawake","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jiac.2025.102859_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jiac.2022.12.008","article-title":"Aseptic meningitis after amenamevir treatment for herpes zoster ophthalmicus with oculomotor nerve palsy in a patient taking immunosuppressant","volume":"29","author":"Omiya","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102859_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jinf.2011.11.014","article-title":"Management of suspected viral encephalitis in adults--association of british neurologists and british infection association national guidelines","volume":"64","author":"Solomon","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2025.102859_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/589747","article-title":"The management of encephalitis: clinical practice guidelines by the infectious diseases society of america","volume":"47","author":"Tunkel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102859_bib19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ndt\/gfg119","article-title":"High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study","volume":"18","author":"Hellden","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jiac.2025.102859_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/jac\/dkl067","article-title":"The aciclovir metabolite cmmg is detectable in the csf of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment","volume":"57","author":"Hellden","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2025.102859_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1248\/yakushi.21-00237","article-title":"[a pharmacist's query avoiding exacerbation of adverse effects in a patient with acyclovir encephalopathy: a case report]","volume":"142","author":"Tai","year":"2022","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jiac.2025.102859_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1193","article-title":"Population pharmacokinetics and dose rationale for aciclovir in term and pre-term neonates with herpes","volume":"12","author":"D'Agate","year":"2024","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jiac.2025.102859_bib23","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1128\/AAC.01138-08","article-title":"Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir","volume":"53","author":"Zeng","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102859_bib24","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/jac\/dkaf070","article-title":"Population pharmacokinetics of aciclovir and its major metabolite 9-carboxymethoxymethylguanine and safety profile of valaciclovir in early liver transplant recipients","volume":"80","author":"Kably","year":"2025","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:25:25Z","timestamp":1773332725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25002569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1341321X25002569"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102859","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of continuous hemodiafiltration on serum acyclovir concentrations in a patient with encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102859"}}